Layered Therapeutic Polymeric Implants for Sustained Antibiotic Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical device-associated infections, particularly in orthopedic applications, are challenging due to low local antibiotic concentrations in tissues with low blood flow, leading to ineffective treatment of infections in areas like bone and cartilage, as commercially available drug-eluting polymeric materials fail to maintain sufficient antibiotic levels over time.
Innovation Solution
The method involves blending therapeutic agents like antibiotics with polymeric materials, layering them with non-therapeutic agent-containing polymeric materials, and consolidating to form implants with controlled additive distribution, ensuring mechanical properties are maintained, and using cross-linking to enhance effectiveness.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If commercially available antibiotic bone cements are used for local delivery of antibiotics, then initial antibiotic concentration can be achieved, but antibiotic release decreases significantly after 24 hours to levels below minimum inhibitory concentration
Solution Approach 1:
The polymeric material is divided into multiple layers with different antibiotic concentrations. The first layer contains a high concentration of antibiotic (at least 10% by weight) to provide immediate therapeutic effect, while the second layer contains a lower concentration to provide sustained release. This segmentation allows the implant to maintain effective antibiotic levels over an extended period without requiring a single homogeneous composition.
Solution Approach 2:
Different regions of the polymeric material are assigned different antibiotic concentrations based on local requirements. The layer in contact with the infected site contains higher antibiotic concentration for immediate efficacy, while deeper layers contain lower concentrations for prolonged release. This local quality variation optimizes both initial impact and duration of action at different spatial locations within the implant.
2Quantity of substance
If therapeutic agents are incorporated throughout the entire polymeric material, then antibiotic delivery is maximized, but mechanical strength and wear properties of the implant are compromised
Solution Approach 1:
The implant is segmented into layers with different functional properties. The first layer contains therapeutic agents for antibiotic delivery, while the second layer is substantially free of therapeutic agents to provide mechanical support. This segmentation allows the implant to achieve both therapeutic efficacy and mechanical integrity by assigning different functions to different layers rather than requiring the entire material to possess both properties simultaneously.
Solution Approach 2:
Therapeutic agents are localized to specific regions (the first layer) rather than being distributed uniformly throughout the entire implant. This local quality approach ensures that antibiotic delivery capacity is maximized in the region where it is most needed (at the implant site), while other regions maintain optimal mechanical properties by being free of therapeutic agent complications.
3Quantity of substance
If high concentration of antibiotic is used in bone cement, then initial antibiotic level is sufficient, but release rate drops below effective levels within 24 hours
Solution Approach 1:
The antibiotic release function is segmented into two distinct layers: the first layer provides high initial concentration release, while the second layer provides sustained lower concentration release. This segmentation creates a staged release profile that maintains productivity (release rate) over time by transitioning from high initial release to sustained prolonged release, preventing the drop below effective levels that occurs with single-layer cements.
Solution Approach 2:
The layered structure ensures continuous useful action by maintaining effective antibiotic release over an extended period. The first layer provides immediate high-level release, and the second layer continues the release process at a sustained rate, eliminating the gap where release would otherwise drop below effective concentrations. This continuity maintains therapeutic effectiveness throughout the critical early healing period.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach achieves sustained release of therapeutic agents at effective concentrations, enhancing infection treatment efficacy by maintaining mechanical integrity and localized antibiotic delivery, reducing the need for prolonged parenteral antibiotics and multiple surgeries.
Implementation Method 1
The gentamicin released from these bone cements reaches 10 μg/cm2/h but decreases significantly to 0.1-1 μg/cm2/h by 24 hr
Data Source
AI summary
Therapeutic polymeric materials, therapeutic polymeric materials containing medical implants and methods for making the same, and related materials are described. Methods of making medical implants containing additives/antibiotics, therapeutic polymers, and materials used therewith also are described. Methods of spatially controlling additive/antibiotic concentrations, non-homogenous distribution of therapeutic agents in polymeric materials and therapeutic medical implants containing layered constructs of polymeric materials are provided. Therapeutic medical implants containing incorporated therapeutic agents in the polymeric materials, for example, antibiotics into polymeric total joint implants, are useful for delivery of the therapeutic agents into the surrounding mediums.